v3.26.1
Restatement of Previously Issued Consolidated Financial Statements - Equity Statement Restatement (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Dec. 27, 2025
Dec. 28, 2024
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01  
Common stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01  
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Preferred stock (in shares) 0 0 0 0
Preferred stock   $ 0 $ 0 $ 0
Beginning balance (in shares) 164,531,712      
Net income $ 54,830 9,926    
Other comprehensive (loss) income $ (30,000) 17,483    
Ending balance (in shares) 164,895,622      
Ending balance $ 796,701 $ 581,435    
Common Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares) 164,531,712 163,842,248    
Beginning balance $ 1,645 $ 1,638    
Stock issued relating to Employee Stock Purchase Plan (in shares) 46,915 44,693    
Stock issued relating to Employee Stock Purchase Plan $ 1 $ 1    
Shares issued for exercise/vesting of share-based compensation awards (in shares) 316,995 393,284    
Shares issued for exercise/vesting of share-based compensation awards $ 3 $ 4    
Forfeiture of restricted stock awards (in shares)   (5,608)    
Forfeiture of restricted stock awards   $ 0    
Ending balance (in shares) 164,895,622 164,274,617    
Ending balance $ 1,649 $ 1,643    
Additional paid-in capital        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance 1,736,416 1,707,573    
Stock issued relating to Employee Stock Purchase Plan 428 523    
Share-based compensation expense 5,715 12,310    
Tax obligations for share-based compensation (1,478) (2,582)    
Ending balance 1,741,081 1,717,824    
Accumulated deficit        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (953,208) (1,093,370)    
Net income 54,830 9,926    
Ending balance (898,378) (1,083,444)    
Accumulated other comprehensive income (loss)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (17,651) (72,071)    
Other comprehensive (loss) income (30,000) 17,483    
Ending balance $ (47,651) $ (54,588)    
As Previously Reported        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Preferred stock (in shares)   0    
Preferred stock   $ 0    
Net income   5,506    
Other comprehensive (loss) income   20,669    
Ending balance   $ 643,243    
As Previously Reported | Common Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   163,842,248    
Beginning balance   $ 1,638    
Stock issued relating to Employee Stock Purchase Plan (in shares)   44,693    
Stock issued relating to Employee Stock Purchase Plan   $ 1    
Shares issued for exercise/vesting of share-based compensation awards (in shares)   393,284    
Shares issued for exercise/vesting of share-based compensation awards   $ 4    
Forfeiture of restricted stock awards (in shares)   (5,608)    
Forfeiture of restricted stock awards   $ 0    
Ending balance (in shares)   164,274,617    
Ending balance   $ 1,643    
As Previously Reported | Additional paid-in capital        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance   1,699,851    
Stock issued relating to Employee Stock Purchase Plan   523    
Share-based compensation expense   11,788    
Tax obligations for share-based compensation   (2,582)    
Ending balance   1,709,580    
As Previously Reported | Accumulated deficit        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance   (1,002,583)    
Net income   5,506    
Ending balance   (997,077)    
As Previously Reported | Accumulated other comprehensive income (loss)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance   (91,572)    
Other comprehensive (loss) income   20,669    
Ending balance   $ (70,903)    
Restatement Impacts        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Preferred stock (in shares)   0    
Preferred stock   $ 0    
Net income   4,420    
Other comprehensive (loss) income   (3,186)    
Ending balance   $ (61,808)    
Restatement Impacts | Common Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance (in shares)   0    
Beginning balance   $ 0    
Stock issued relating to Employee Stock Purchase Plan (in shares)   0    
Stock issued relating to Employee Stock Purchase Plan   $ 0    
Shares issued for exercise/vesting of share-based compensation awards (in shares)   0    
Shares issued for exercise/vesting of share-based compensation awards   $ 0    
Forfeiture of restricted stock awards (in shares)   0    
Forfeiture of restricted stock awards   $ 0    
Ending balance (in shares)   0    
Ending balance   $ 0    
Restatement Impacts | Additional paid-in capital        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance   7,722    
Stock issued relating to Employee Stock Purchase Plan   0    
Share-based compensation expense   522    
Tax obligations for share-based compensation   0    
Ending balance   8,244    
Restatement Impacts | Accumulated deficit        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance   (90,787)    
Net income   4,420    
Ending balance   (86,367)    
Restatement Impacts | Accumulated other comprehensive income (loss)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Beginning balance   19,501    
Other comprehensive (loss) income   (3,186)    
Ending balance   $ 16,315